afdx 384 has been researched along with fluoxetine in 1 studies
| Studies (afdx 384) | Trials (afdx 384) | Recent Studies (post-2010) (afdx 384) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
|---|---|---|---|---|---|
| 78 | 0 | 6 | 10,100 | 1,663 | 3,263 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, B; Gibbons, AS; Jeon, WJ; Scarr, E | 1 |
1 other study(ies) available for afdx 384 and fluoxetine
| Article | Year |
|---|---|
Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Muscarinic Agonists; Oxotremorine; Pirenzepine; Radiopharmaceuticals; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium | 2016 |